Caredx presents new data at the american society for histocompatibility and immunogenetics annual meeting

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced a leading presence at the 49th annual meeting of the american society for histocompatibility and immunogenetics (ashi) being held in san antonio, texas from october 16-20, 2023. the latest advances across caredx's portfolio of hla.
CDNA Ratings Summary
CDNA Quant Ranking